Buy ANY 5 Biomaterial Products, Receive 1 at No Cost! Use code B5G1Q125 Learn More
GEM 21S®, the first recombinant growth factor product for use in oral regenerative surgery. Learn More
CLINICAL CASE
1 – Thin mucosal tissue over implant #7 creating an unesthetic appearance.2 – Occlusal view of #7 reveals buccal soft-tissue defects.3 – Augmentation of the soft-tissue on two implant sites, #7 and #10, using a conventional full thickness flap with vertical releasing incisions on site #7 and an envelope flap on site #10.4 – Geistlich Fibro-Gide® is split into two 3mm thick matrices to be used in both sites, hydrated with sterile saline and trimmed to the defect dimensions.5 – Geistlich Fibro-Gide® is secured to the periosteum apically and the interproximal papillae with 5-0 chromic gut sutures.6 – Passive closure of the flap achieved with 6-0 vicryl sutures.7 – 1 week post-surgery reveals uneventful healing with maintenance of tissue volume.8 – Buccal view at 8 weeks reveals uneventful healing with maintenance of tissue volume.9 – Occlusal view at 8 weeks post-surgery.